Figure S2 from Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis

2026 Open access

Read full text
Authors: Charles H. Earnshaw, Poppy Dunn, Shih‐Chieh Chiang, Agrin Moeini, Maria A. Koufaki, Eduardo Bonavita, Massimo Russo, Laëtitia Nebot-Bral, Kimberley Hockenhull, Erin Richardson, Anna Pidoux, Charlotte R. Bell
+12 more Alexander R. Baker, Richard Reeves, Robert Sellers, Sudhakar Sahoo, Victoria Elisabeth Richardsdot Fife, Matthew G. Roberts, Theophile Bigirumurame, Caroline Dive, Julia Newton‐Bishop, Jérémie Nsengimana, Christopher E.M. Griffiths, Santiago Zelenay
DOI: 10.1158/2159-8290.31296722
Cited by: 0

Abstract

Supplementary Figure 2. Topical GC treatment of 20967 tumors reduce leukocyte counts systemically.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers TGF-β signaling in diseases Cancer Stress Anesthesia and Immune Response

Publication details

Publication date
9 February 2026
Language
EN